Atherosclerotic Cardiovascular Disease

Menopausal hormone therapy for bothersome vasomotor or other symptoms is safe and appropriate for most women at low atherosclerotic CVD risk, whereas a nuanced approach is needed for intermediate-risk women, researchers reported.

Long-term prediction tools can further discriminate a subgroup of young adults with elevated atherosclerotic CVD risk as candidates for preventive therapy despite having low estimated short-term risk, researchers reported.

A healthy lifestyle was associated with reduced risk for CVD among adults with familial hypercholesterolemia regardless of their familial hypercholesterolemia mutation status, researchers reported.

Suboptimal uses of statin therapy, aspirin prescription and lifestyle counseling persist for adults with atherosclerotic CVD, despite new guidelines emphasizing their effect on reduced mortality, researchers reported.

Researchers in France observed that maternal inheritance of familial hypercholesterolemia was associated with greater odds of having subclinical coronary atherosclerosis compared with paternal inheritance of the gene mutation.

In two prospective cohort studies and a meta-analysis of present and past studies, elevated LDL triglycerides were associated with increased risk for atherosclerotic CVD and its components, researchers reported.

Healio and Cardiology Today have compiled a list of the most-read headlines of December 2022 in cardiology.

Initiation rates of GLP-1 receptor agonists and SGLT2 inhibitors among older adults with type 2 diabetes and atherosclerotic cardiovascular disease or congestive heart failure remained low from 2016 to 2019, according to study data.

Even in the COVID-19 era, atherosclerotic CVD remains the leading cause of death worldwide.

The American College of Cardiology announced the late-breaking science lineup for its Scientific Session to be held March 4-6, 2023 in New Orleans and online.